Canada - engelsk - Health Canada

novartis pharmaceuticals canada inc - lutetium (177lu) oxodotreotide - solution - 370mbq - lutetium (177lu) oxodotreotide 370mbq - antineoplastic agents

Schweiz - tysk - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - lutetium(177-lu(ca)) oxodotreotidum - infusionslösung - lutetium(177lu(ca)) oxodotreotidum 370 mbq, acidum aceticum, natrii acetas, acidum penteticum, natrii chloridum, natrii hydroxidum, acidum gentisicum, e 300, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.24 mg. - gastroenteropankreatische neuroendokrine tumore (gep‑net) - radiopharmazeutika

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣諾華股份有限公司 臺北市中山區民生東路3段2號8樓 (01516589) - 177lu-dota0-tyr3-octreotate - 注射液劑 - 主成分 () ; 177lu-dota0-tyr3-octreotate (9900008500) mbq - lutetium (177lu) oxodotreotide - 用於治療成人無法手術切除或轉移性，分化良好(g1及g2)且經體抑素類似物(somatostatin analogue)治療無效之體抑素受體(somatostatin receptor)陽性的胃腸道胰腺神經內分泌腫瘤(gep-nets)。